"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

Ozempic, a drug initially intended for type 2 diabetes treatment, is gaining popularity for weight loss and reducing ...

Semaglutide, the active ingredient in Ozempic, has shown promising results in weight loss ... “Additionally, many women ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Millions of people across the world benefit from weight loss drugs such as Ozempic based on the hormone GLP-1 ... Unlike ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

The UK’s drug’s watchdog has warned people over the use of counterfeit medications which could contain insulin - with many ...

On Wednesday, Novo Nordisk A/S (NYSE:NVO) reported third-quarter 2024 sales of 71.311 billion Danish kroner (around $10.3 ...